EA202092762A1 - MONOHYDRATE AND CRYSTALLINE FORMS 6 - [(3S, 4S) -4-METHYL-1- (PYRIMIDIN-2-YLMETHYL) PYRROLIDIN-3-YL] -3-TETRAHYDROPYRAN-4-IL-7H-IMIDAZO [1,5-a ] PIRAZIN-8-ONA - Google Patents

MONOHYDRATE AND CRYSTALLINE FORMS 6 - [(3S, 4S) -4-METHYL-1- (PYRIMIDIN-2-YLMETHYL) PYRROLIDIN-3-YL] -3-TETRAHYDROPYRAN-4-IL-7H-IMIDAZO [1,5-a ] PIRAZIN-8-ONA

Info

Publication number
EA202092762A1
EA202092762A1 EA202092762A EA202092762A EA202092762A1 EA 202092762 A1 EA202092762 A1 EA 202092762A1 EA 202092762 A EA202092762 A EA 202092762A EA 202092762 A EA202092762 A EA 202092762A EA 202092762 A1 EA202092762 A1 EA 202092762A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tetrahydropyran
imidazo
pyrrolidin
pyrimidin
ylmethyl
Prior art date
Application number
EA202092762A
Other languages
Russian (ru)
Inventor
Сюзанна Баттар
Матеуш Питак
Адам Росс Паттерсон
Сэмюэл Александр Стратфорд
Иоана Соваго
Цзюнь Сюй
Пэн Чжоу
Хаоцзюань Вэй
Куанчу Дай
Original Assignee
Имара Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имара Инк. filed Critical Имара Инк.
Priority claimed from PCT/US2019/033835 external-priority patent/WO2019226944A1/en
Publication of EA202092762A1 publication Critical patent/EA202092762A1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к кристаллическим полиморфным формам 6-[(3S,4S)-4-метил-1-(пиримидин-2-илметил)пирролидин-3-ил]-3-тетрагидропиран-4-ил-7H-имидазо[1,5-a]пиразин-8-она.The present invention relates to crystalline polymorphic forms 6 - [(3S, 4S) -4-methyl-1- (pyrimidin-2-ylmethyl) pyrrolidin-3-yl] -3-tetrahydropyran-4-yl-7H-imidazo [1, 5-a] pyrazin-8-one.

EA202092762A 2019-01-04 2019-05-23 MONOHYDRATE AND CRYSTALLINE FORMS 6 - [(3S, 4S) -4-METHYL-1- (PYRIMIDIN-2-YLMETHYL) PYRROLIDIN-3-YL] -3-TETRAHYDROPYRAN-4-IL-7H-IMIDAZO [1,5-a ] PIRAZIN-8-ONA EA202092762A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962788323P 2019-01-04 2019-01-04
PCT/US2019/033835 WO2019226944A1 (en) 2018-05-25 2019-05-23 Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one

Publications (1)

Publication Number Publication Date
EA202092762A1 true EA202092762A1 (en) 2021-05-13

Family

ID=76160094

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092762A EA202092762A1 (en) 2019-01-04 2019-05-23 MONOHYDRATE AND CRYSTALLINE FORMS 6 - [(3S, 4S) -4-METHYL-1- (PYRIMIDIN-2-YLMETHYL) PYRROLIDIN-3-YL] -3-TETRAHYDROPYRAN-4-IL-7H-IMIDAZO [1,5-a ] PIRAZIN-8-ONA

Country Status (1)

Country Link
EA (1) EA202092762A1 (en)

Similar Documents

Publication Publication Date Title
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
PE20180501A1 (en) BICYCLE BEDS AND METHODS OF USING THEM
ATE517897T1 (en) HETEROBICYCLIC INHIBITORS OF HVC
MA43288B1 (en) Production processes and crystal forms of an mdm2 inhibitor
EA200801372A1 (en) METHODS OF OBTAINING SUBSTITUTED PYRIMIDINES
EA200401157A1 (en) N-AMINOACETYLPYRROLIDIN-2-CARBONITRYLES AND THEIR APPLICATION AS DDP-IV Inhibitors
BRPI0513310A (en) tetrapeptide analogs
EA200500169A1 (en) SUBSTITUTED DERIVATIVES 1,3-DIPHENYLPROP-2-EN-1-SHE, RECEIVING AND APPLICATION
BRPI0414599A (en) substituted pyrrol indoles
CR9591A (en) PROTEIN CINASE INHIBITORS DERIVED FROM PIRROL (2,3-B) PIRIDINE
EA201400135A1 (en) HINAZOLINS SUBSTITUTED, THEIR RECEPTION AND THEIR APPLICATION IN PHARMACEUTICAL COMPOSITIONS
MXPA05013553A (en) Pyrrolodihydroisoquinolines as pde10 inhibitors.
ATE417051T1 (en) POLYMORPHS OF CLOPIDOGREL HYDROSULFATE
ATE510822T1 (en) POTASSIUM CHANNEL INHIBITORS
EA201790838A1 (en) KINASE INHIBITOR AURORA A
ATE549024T1 (en) QUINAZOLINE POTASSIUM CHANNEL INHIBITORS
MX2023009562A (en) Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one.
MX2021011524A (en) Prmt5 inhibitors and uses thereof.
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK1926732T3 (en) PROCEDURE FOR THE PREPARATION OF CARBAPENNAM RELATIONS
WO2018170236A9 (en) Cdpk1 inhibitors, compositions and methods related thereto
EA202092762A1 (en) MONOHYDRATE AND CRYSTALLINE FORMS 6 - [(3S, 4S) -4-METHYL-1- (PYRIMIDIN-2-YLMETHYL) PYRROLIDIN-3-YL] -3-TETRAHYDROPYRAN-4-IL-7H-IMIDAZO [1,5-a ] PIRAZIN-8-ONA
ATE335739T1 (en) CAK INHIBITORS AND THEIR USES
EA201891430A1 (en) SOLID FORMS OF SUBSTITUTED 5,6-DIHYDRO-6-PHENILBENZO [F] IZOHINOLIN-2-AMINE COMPOUNDS
BRPI0413982A (en) alpha-aminoamide derivatives useful as anti-inflammatory agents